 | VERONA PHARMA P/S (NASDAQ:VRNA) Short Interest Update
www.americanbankingnews.com - January 26 at 6:58 PM |
 | Verona Pharma: Not Enough Cash To Demonstrate The Clinical Benefit For Its Key Drug Candidate
seekingalpha.com - January 23 at 4:01 PM |
| VERONA PHARMA P/S (NASDAQ:VRNA) Expected to Announce Earnings of -$1.12 Per Share
www.americanbankingnews.com - January 20 at 2:22 AM |
| Head-To-Head Review: Jaguar Health (NASDAQ:JAGX) versus VERONA PHARMA P/S (NASDAQ:VRNA)
www.americanbankingnews.com - January 18 at 5:56 AM |
| VERONA PHARMA P/S Expected to Post FY2020 Earnings of ($3.02) Per Share (NASDAQ:VRNA)
www.americanbankingnews.com - January 17 at 10:45 AM |
| VERONA PHARMA P/S (NASDAQ:VRNA) to Post FY2024 Earnings of $0.89 Per Share, Wedbush Forecasts
www.americanbankingnews.com - January 15 at 8:06 AM |
| VERONA PHARMA P/S (NASDAQ:VRNA) Price Target Raised to $34.00 at SunTrust Banks
www.americanbankingnews.com - January 14 at 9:23 AM |
| Verona Pharma up 59% premarket on positive ensifentrine data
seekingalpha.com - January 13 at 5:37 PM |
| VERONA PHARMA P/S (NASDAQ:VRNA) PT Raised to $60.00 at Wedbush
www.americanbankingnews.com - January 13 at 4:57 PM |
 | Verona Pharma Says Ensifentrine Study Shows Positive Results
www.lse.co.uk - January 13 at 3:46 AM |
 | Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
www.benzinga.com - January 13 at 3:46 AM |
| VERONA PHARMA P/S (NASDAQ:VRNA) Sees Significant Increase in Short Interest
www.americanbankingnews.com - January 11 at 1:58 AM |
 | Big Day Awaits Verona Pharma (VRNA) On Monday
www.nasdaq.com - January 10 at 9:16 PM |
 | Verona Pharma to Participate in Two Upcoming Institutional Investor Conferences in New York
finance.yahoo.com - November 11 at 8:30 AM |
| Verona Pharma plc (VRNA) CEO Jan-Anders Karlsson on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 9:13 AM |
| Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory Society International Congress 2019
finance.yahoo.com - September 30 at 3:52 PM |
| Verona Pharma to Present at H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 10:51 AM |
| Verona Pharma plc: PDMR Dealing
finance.yahoo.com - August 9 at 9:12 AM |
| Verona Pharma plc: Operational Update and Financial Results for the Three and Six Months Ended June 30, 2019
finance.yahoo.com - August 6 at 9:41 AM |
| Verona Pharma Reports Positive Phase 2 Results with Dry Powder Inhaler Formulation of Ensifentrine in COPD
finance.yahoo.com - August 5 at 9:39 AM |
| Verona Pharma to Announce Financial Results for Second Quarter Ended June 30, 2019 and Provide Clinical Development Update
finance.yahoo.com - July 30 at 9:31 AM |
| Verona Pharma to Attend BTIG Biotechnology Conference 2019 and Present at 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - July 24 at 10:15 AM |
| Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
finance.yahoo.com - June 4 at 9:52 AM |
| Verona Pharma to Present at Jefferies 2019 Global Healthcare Conference
finance.yahoo.com - May 30 at 9:49 AM |
| Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference
finance.yahoo.com - May 20 at 1:13 PM |
 | Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials
www.globenewswire.com - May 7 at 9:42 AM |
| Verona Pharma plc ("Verona" or the "Company") Appointment of Nominated Adviser and UK Broker
www.nasdaq.com - May 1 at 9:35 AM |
| Verona Pharma plc ("Verona" or the "Company") Appointment of Nominated Adviser and UK Broker
finance.yahoo.com - May 1 at 9:35 AM |
| Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019
finance.yahoo.com - April 25 at 9:46 AM |
| Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine
finance.yahoo.com - April 9 at 10:21 AM |
| Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 26 at 9:56 AM |
| Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director
finance.yahoo.com - March 21 at 8:05 AM |
| Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update
finance.yahoo.com - February 26 at 10:18 AM |
| Verona Pharma Works Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - February 1 at 9:59 AM |
| Verona Pharma Enters Oversold Territory
finance.yahoo.com - January 16 at 9:39 AM |
| Verona Pharma's nebulized ensifentrine shows mixed results in pharmacology study
seekingalpha.com - January 14 at 9:15 AM |
| Verona Pharma Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - January 11 at 10:08 AM |
| Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
finance.yahoo.com - January 9 at 9:52 AM |
 | Verona Pharma PLC American Depositary Share (VRNA)
www.zacks.com - January 4 at 4:47 PM |
 | Verona Pharma PLC ADR
www.barrons.com - December 18 at 4:34 PM |
 | Verona Pharma plc (VRNA) Commences Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
www.streetinsider.com - December 17 at 9:42 AM |
| Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
finance.yahoo.com - December 17 at 9:42 AM |
